# Universal Newborn Screening For Sickle Cell Disease In Mozambique

> **NCT07719972** · NA · NOT_YET_RECRUITING · sponsor: **St. Jude Children's Research Hospital** · enrollment: 6750 (estimated)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **OTHER:** Point-of-care testing (POCT) -Patient participants
- **OTHER:** Point-of-care testing (POCT) - Healthy control participants
- **OTHER:** Context Assessment for Community Health (COACH) survey
- **OTHER:** Semi-structured interview

## Key facts

- **NCT ID:** NCT07719972
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2031-08
- **Final completion:** 2031-08
- **Target enrollment:** 6750 (ESTIMATED)
- **Last updated:** 2026-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07719972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07719972, "Universal Newborn Screening For Sickle Cell Disease In Mozambique". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07719972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*